Abstract
Background Residents of long-term care facilities (LTCFs) have been disproportionately affected during the COVID-19 pandemic. To inform decision-making around interventions, we quantified the SARS-CoV-2 infection risk for residents and the relative contribution of different infection sources. We estimated the force of infection (FOI) experienced by Dutch LTCF residents over time and quantified the contribution of residents, LTCF healthcare workers (HCWs), and the general population.
Methods & findings Case data were obtained by Municipal Health Services as part of the Dutch national surveillance program. During the study period (1 October 2020 to 10 November 2021), testing policies included symptom-based testing, exposure-based testing, and facility-wide serial testing. We used a data augmentation approach to include uncertainty in the timing of infection, while taking account of different testing policies. We constructed a Bayesian generalized linear model to estimate group-specific transmission rate parameters and contributions to the FOI experienced by residents.
During the study period 36,877 cases were registered among residents and 19,676 among HCWs. The total daily FOI towards residents was highest in December 2020 (1.7*10−3, 95% CI: 1.5*10−3 – 1.9*10−3) and lowest in June 2021 (1.1*10−5 95%CI: 7.6*10−6 – 1.7*10−5). Resident-directed type-reproduction numbers and FOI declined as COVID-19 vaccination rollout started in residents, HCWs, and the older general population (February-May 2021). Most resident infections in spring and summer 2021 were attributable to infections in the general population. The relative contribution of the general population to the FOI decreased in summer 2021 when vaccination was available population-wide. In October-November 2021, type-reproduction numbers and FOI increased again. We observed an increase in residents’ susceptibility to infection in this period, which was only partially explained by the emergence of the Delta variant. Sensitivity analyses showed that the temporal trends in relative contributions to the FOI were not impacted by assumptions about immunity build-up among residents, nor by underreporting of infections.
Conclusions COVID-19 vaccination appears to have been effective in reducing SARS-CoV-2 transmission towards residents, although other factors such as seasonality or non-pharmaceutical interventions may also have contributed to this. This effect seemed to have decreased by autumn 2021, which could be due to waning of immunity or changes in control practices. Our estimates of temporal trends in relative contributions to the FOI in LTCF residents can help target intervention efforts.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was financed by the Netherlands Ministry of Health, Welfare and Sport.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was not applicable for this study as this study did not meet the conditions to require ethical approval under Dutch law (WMO).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data hold by the RIVM can be requested by contacting datastewards@rivm.nl. Other data mentioned in the manuscript needs to be requested by the named institutes, as these were provided under contract.
